Skip to main content

Table 5 Distribution of primary health care staff who agree about perceived capacity and motivation to conduct direct observed treatment for multidrug-resistant tuberculosis patients

From: Being safe, feeling safe, and stigmatizing attitude among primary health care staff in providing multidrug-resistant tuberculosis care in Bantul District, Yogyakarta Province, Indonesia

Domains of attitude Total (N = 123) Type of staff Working at PHCs which provide DOT for MDR-TB Received on-the-job training on DOT for MDR-TB procedure Received training on infection control
Clinical staffa
(N = 95)
TB program staff (N = 10) Other staffb (N = 18) p Yes (N = 39) No (N = 84) p Yes (N = 36) No (N = 87) p Yes (N = 75) No (N = 48) p
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Perceived capacity
 I am confident conducting DOT for MDR-TB patient. 81 (65.9) 62 (65.3) 9 (90.0) 10 (55.6) 0.178 32 (82.1) 49 (58.3) 0.01 31 (86.1) 50 (57.5) 0.002 52 (69.3) 29 (60.4) 0.309
 I understand the DOT procedure for MDR-TB patient. 72 (58.6) 58 (61.1) 7 (70.0) 7 (38.9) 0.161 31 (79.5) 41 (48.8) 0.001 32 (88.9) 40 (46.0) < 0.001 48 (64.0) 24 (50.0) 0.124
 Infection control is properly managed in the PHC. 66 (53.7) 47 (49.5) 4 (40.0) 15 (83.3) 0.020 24 (61.5) 42 (50.0) 0.232 20 (55.6) 46 (52.9) 0.786 36 (48.0) 30 (62.5) 0.116
Motivation
 If there were a choice, I would prefer not to conduct DOT for MDR-TB patients. 33 (26.8) 28 (29.5) 1 (10.0) 9 (22.2) 0.319 9 (23.1) 24 (28.6) 0.522 6 (16.7) 27 (31.0) 0.158 17 (22.7) 16 (33.3) 0.193
 I think I should be involved in TB control by doing DOT for MDR-TB patients. 83 (67.5) 60 (63.2) 10 (100) 13 (72.2) 0.055 28 (71.8) 55 (65.5) 0.486 30 (83.3) 53 (60.9) 0.016 57 (76.0) 26 (54.2) 0.012
  1. aClinical staff: medical doctor, nurse, and laboratory staff. bOther staff: registration staff, health promotion staff, and environmental health staff. Data analysis used the Pearson chi-square test
  2. TB tuberculosis, PHCs primary health care facilities, DOT direct observed treatment, MDR-TB multidrug-resistant tuberculosis